News
Posted: April 29, 2025 | News
CitraFlow: The Solution for Catheter-Related Bacteraemia and Clotting of Catheters
Amsino, in collaboration with its subsidiary MedXL, a leading manufacturer of pre-filled syringes, hosted an in-depth seminar on CitraFlow™ sodium citrate syringes on April 10, 2025, during the CMEF.
The seminar highlighted the significance of CitraFlow prefilled syringes for catheters, particularly in relation to bacterial contamination and dialysis catheter maintenance.
Posted: April 10, 2025 | News
Amsino Announces New Boston Location
Press Release Amsino International, Inc. Boston. April 4, 2025.
Amsino has taken a significant step forward in our mission to advance healthcare worldwide. We are proud to announce the establishment of Amsino Scientific Inc., a new medical device manufacturing, research, and development facility based in Franklin, Massachusetts.
Posted: November 25, 2024 | News, Press
Amsino Expands North American Manufacturing and Doubles Capacity with the Acquisition of MedXL Inc.
Amsino International Inc. announced the successful closing of transactions today to acquire the assets of MedXL, Inc., located in Quebec, Canada. This acquisition includes all existing assets and infrastructure at MedXL facilities, such as intellectual properties, real estate properties, manufacturing equipment, and global product registrations in approximately 60 countries.
Posted: October 15, 2024 | News
2024 Amsino Holiday Closures
As we approach the holiday season, we want to inform you of Amsino’s upcoming holiday closures and year-end shipping schedule.
Posted: July 24, 2024 |
Amsino Acquires Enteral Feeding Pump Products from Alcor Scientific
Amsino Medical Group Company (“Amsino”), a global provider of medical consumable devices, announced today that it has acquired Alcor Scientific’s enteral feeding pump products, including Sentinel and SentinelPlus.
Posted: June 26, 2024 | News, Press
Amsino Medical Group Company announces transformational investment from Novo Tellus
Amsino Medical Group, a global provider of medical consumable devices, is pleased to announce the closing of a substantial investment by Novo Tellus, a leading investment firm specialising in long-term investments in the global supply chain.
Posted: October 24, 2023 | News
Amsino Shanghai Welcomes Visitors from ICU Medical Japan
Amsino was honored to welcome visitors from ICU Medical Japan. Dr. Richard Lee, CEO and Chairman of Amsino Medical Group awarded them for the outstanding sales and marketing of RECEPTAL Twist in 2022. "We are very pleased to see RECEPTAL's continuous growth in the Japan market which was supported by the successful launch of Twist. We are grateful for your efforts and cooperation always" said Dr. Richard Lee in the meeting.
Posted: September 25, 2023 |
Amsino Granted US Patent for RECEPTAL Twist
Amsino Medical Co. Ltd. is proud to share that the United States Patent and Trademark Office (USPTO) has approved our application for a patent for RECEPTAL Twist. The Twist system was developed by Amsino President and CEO, Dr. Richard Lee, in partnership with Amsino Research Fellow, Zhongze Li.
Posted: August 21, 2023 | News
Amsino to Exhibit at MEDICA 2023
Pomona, CA – August 21, 2023 | Amsino International, Inc. is excited to be exhibiting at MEDICA later this year! MEDICA will take place in Düsseldorf, Germany from 13-16 November 2023.